Yoshinori Shirafuji, Yoshinobu Maeda, Keiji Iwatsuki. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents/therapeutic useCryoglobulins/adverse effectsCryoglobulins/therapeutic useCyanosis/chemically inducedCyanosis/diagnosisCyanosis/drug therapyFingersFollow-Up StudiesHemagglutinins/adverse effectsHemagglutinins/therapeutic useHumansLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyMaleMiddle AgedRituximab
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsCryoglobulinsHemagglutininscold agglutininsRituximab
Year: 2010 PMID： 20139040 DOI： 10.1684/ejd.2010.0908
Source DB: PubMed Journal: Eur J Dermatol ISSN： 1167-1122 Impact factor: 3.328